NEWS
One of Eli Lilly‘s patents on Gemzar invalidated; may shave off 3 years of exclusivity – the method of use patent for its cancer drug Gemzar was invalidated by a federal court in Michigan, the drugmaker said today…more
Merck‘s Gardasil vaccine safe overall, though some questions about promotional practices – two researchers at Columbia College of Physicians and Surgeons reported that Merck wrongly got professional medical groups to help promote its vaccine through speakers who didn’t provide balanced recommendations concerning Gardasil’s risks and benefits…more
Canadian study: GSK‘s Avandia does have more heart risks than Takeda‘s Actos – Researchers analyzed prescription data for 39,736 patients ages 66 and older who were enrolled in the Ontario Public Drug Benefit Program and began taking Avandia or Actos from April 2002 to March 2008. During the six-year study, 6.9 percent of patients on Avandia died or were hospitalized for a heart attack or heart failure, compared with 5.3 percent of those on Actos…more
So – what about Key Account Management? Some thoughts from Pharmaceutical Executive.
RECOMMENDED
Are you looking at social media applications, either in-house (enterprise communications) or outward-facing (marketing communications)? I can help, with strategy consultation and vendor/provider recommendations. Contact me (stevew at impactiviti dot com) and let’s talk! (In the meantime, download my free e-book, Getting Started with Social Networking)
ePharma Review: My take on Novartis Oncology’s CML Earth. A very good start here for a social media platform; still room for improvement.
PLUS
Thought-provoking: People don’t Leave Organizations – They Leave Managers. AND – from my StickyFigure blog – Ask the Right Questions. Where you start determines where you end up…
———-
Subscribe to the Impactiviti blog via e-mail
Connect with Steve Woodruff
Leave a Reply